down arrow

Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
232.20
6.7 (2.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.39 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

227.00235.80

52 Week

190.00385.50
Valuation
Technical
Day's Volume

CASH

17.39 k (-56.67%) Volume

Shareholding (Dec 2024)

FII

1.25%

Held by 36 FIIs

DII

18.90%

Held by 21 DIIs

Promoter

58.80%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -4.03% of over the last 5 years

 
2

With a fall in PBT of -314.48%, the company declared Very Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,142 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.66%

stock-summary
Debt Equity

0.73

stock-summary
Return on Equity

2.25%

stock-summary
Price to Book

1.91

Revenue and Profits (1 Year):
Net Sales:
411 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-26 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.66%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-31.09%
0%
-31.09%
1 Year
-34.03%
0.45%
-33.58%
2 Years
-30.21%
1.10%
-29.11%
3 Years
-41.57%
1.36%
-40.21%
4 Years
-26.57%
1.71%
-24.86%
5 Years
-5.67%
2.99%
-2.68%

Latest dividend: 1.5 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.79%
EBIT Growth (5y)
-4.03%
EBIT to Interest (avg)
7.37
Debt to EBITDA (avg)
1.70
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.18
Tax Ratio
100.00%
Dividend Payout Ratio
14.04%
Pledged Shares
0
Institutional Holding
20.15%
ROCE (avg)
13.47%
ROE (avg)
10.65%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.91
EV to EBIT
76.35
EV to EBITDA
19.29
EV to Capital Employed
1.53
EV to Sales
1.67
PEG Ratio
NA
Dividend Yield
0.66%
ROCE (Latest)
4.93%
ROE (Latest)
2.25%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (18.21%)

FIIs

Held by 36 FIIs (1.25%)

Promoter with highest holding

Spa Holdings Pvt Ltd (19.89%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (4.81%)

Individual Investors Holdings

16.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -5.11% vs 0.27% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -175.76% vs -465.27% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "410.55",
          "val2": "432.66",
          "chgp": "-5.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.03",
          "val2": "40.25",
          "chgp": "-70.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.11",
          "val2": "17.83",
          "chgp": "-9.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.99",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-26.39",
          "val2": "-9.57",
          "chgp": "-175.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.99%",
          "val2": "9.35%",
          "chgp": "-6.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -4.85% vs 7.96% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -111.67% vs -32.66% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "864.16",
          "val2": "908.23",
          "chgp": "-4.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.03",
          "val2": "132.53",
          "chgp": "-33.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "32.14",
          "val2": "15.91",
          "chgp": "102.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.94",
          "val2": "59.46",
          "chgp": "-111.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.30%",
          "val2": "14.88%",
          "chgp": "-4.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -6.80% vs 10.25% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -143.99% vs -34.94% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,274.71",
          "val2": "1,367.65",
          "chgp": "-6.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "100.06",
          "val2": "195.43",
          "chgp": "-48.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "48.25",
          "val2": "25.98",
          "chgp": "85.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.99",
          "val2": "-8.20",
          "chgp": "112.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-33.33",
          "val2": "75.76",
          "chgp": "-143.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.85%",
          "val2": "14.29%",
          "chgp": "-6.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 8.91% vs 8.30% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -30.78% vs -8.11% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,817.29",
          "val2": "1,668.61",
          "chgp": "8.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "244.31",
          "val2": "286.10",
          "chgp": "-14.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "38.02",
          "val2": "25.03",
          "chgp": "51.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.53",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.47",
          "val2": "142.25",
          "chgp": "-30.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.66%",
          "val2": "17.44%",
          "chgp": "-3.78%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
410.55
432.66
-5.11%
Operating Profit (PBDIT) excl Other Income
12.03
40.25
-70.11%
Interest
16.11
17.83
-9.65%
Exceptional Items
0.99
0.00
Consolidate Net Profit
-26.39
-9.57
-175.76%
Operating Profit Margin (Excl OI)
2.99%
9.35%
-6.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -5.11% vs 0.27% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -175.76% vs -465.27% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
864.16
908.23
-4.85%
Operating Profit (PBDIT) excl Other Income
88.03
132.53
-33.58%
Interest
32.14
15.91
102.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.94
59.46
-111.67%
Operating Profit Margin (Excl OI)
10.30%
14.88%
-4.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -4.85% vs 7.96% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -111.67% vs -32.66% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,274.71
1,367.65
-6.80%
Operating Profit (PBDIT) excl Other Income
100.06
195.43
-48.80%
Interest
48.25
25.98
85.72%
Exceptional Items
0.99
-8.20
112.07%
Consolidate Net Profit
-33.33
75.76
-143.99%
Operating Profit Margin (Excl OI)
7.85%
14.29%
-6.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -6.80% vs 10.25% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -143.99% vs -34.94% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,817.29
1,668.61
8.91%
Operating Profit (PBDIT) excl Other Income
244.31
286.10
-14.61%
Interest
38.02
25.03
51.90%
Exceptional Items
11.53
0.00
Consolidate Net Profit
98.47
142.25
-30.78%
Operating Profit Margin (Excl OI)
13.66%
17.44%
-3.78%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 8.91% vs 8.30% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -30.78% vs -8.11% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Indoco Remedies Ltd stock-summary
stock-summary
Indoco Remedies Ltd
Small Cap
Pharmaceuticals & Drugs
Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research. The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Coordinates stock-summary
Company Details
Indoco House 166 C S T Road, Santacruz (East) Kalina Mumbai Maharashtra : 400098
stock-summary
Tel: 91-022-26541851-55
stock-summary
http://www.indoco.com
stock-summary
jagdishs@indoco.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."